drug interaction with smoking, 1907t

Chlorhexidine gluconate, 1975

Chloride, 23

blood chemistry reference values for, 17t

Chloromycetin (see Chloramphenicol)

Chloroprocaine, 1177t

Chloroquine, 49, 707, 1695, 1697t

psoriasis and, 834

Chlorpheniramine (Chlor-Trimeton), 433t

Chlorpromazine, 1267, 1789t, 1797t, 1799t

drug interaction with smoking, 1906t

for hyperprolactinemia, 1803

for schizophrenia, 1793t

Chlorpropamide, 1140

Chlorthalidone, 148

Chlorzoxazone, 1186t

Cholecalciferol, 2277t

Cholestyramine, 127, 709

for IBS-D, 536

for thyroid storm, 1067

Cholinesterase inhibitors (ChEIs), 1267

for Alzheimer’s disease, 2238

for DLB, 2240

for PDD, 2240

for vascular dementia, 2242

Chondroitin, 867

Chorioamnionitis, 992

Chromium, 822t

Ciclesonide (Omnaris, Zetonna), 441t

for allergic rhinitis, 442

Ciclopirox, 1624t

Cidofovir (Vistide), 734–735, 1613, 1649t, 1651

adjunctive therapy, 1608t

adjusted dosage, 1610t

advantages, 1608t

adverse effects, 1647t

for CMV retinitis, 1612

CrCl, 1610t

disadvantages, 1608t

dosing regimens, 1608t

for herpes simplex keratitis, 1168

important drug interactions, 1608t

monitoring requirement, 1609t

normal dosage, 1610t

precautions and contraindications, 1609t

select adverse effects, 1608t

Cilostazol, 169, 1307t, 1314

for diabetes, 168

for IC, 168

Cimetidine, 483t, 484, 977, 2163t

inhibition of CYP450 isoenzymes, 484

for preventing SRMB, 515t

for theophylline metabolism inhibition, 398

Cinacalcet, 622

Cinnamates, 849t, 852

Cinoxate, 849t

Cipro (see Ciprofloxacin)

Ciprofloxacin (Cipro), 462, 464, 484, 663, 942t, 1326t, 1376, 1394, 1724

and AIN, 645

for aerobic gram-positive cocci, 1326t

for anaerobes, 1328t

for CAPD-associated peritonitis, 1476t

for COPD, 424

dosing of, 1337t

for MAC, 1619

for S. dysenteriae type 1 infection, 1457

for travelers’ diarrhea, 1461t

for UTI, 1489t, 1497t

for cystic fibrosis, 461t

for tularemia, 1724

Cisatracurium, 47

Cisplatin, 469t, 1972, 1979t, 1981t, 1982t

and cranial neuropathies, 1987

gonadal toxicity of, 1997–1998

and hypokalemia, 583t

monitoring hydration for, 2005

nephrotoxicity of, 1990–1991, 2005

for neuroblastoma, 2003, 2005

neurotoxicity of, 1985t, 1987

for NSCLC, 2062t, 2063t, 2064t, 2065

for osteosarcoma, 2008–2009

peripheral nerve toxicity of, 1986

and renal insufficiency, 1991t

for SCLC, 2068–2069, 2068t

weight gain with, 2005

Citalopram (Celexa), 328, 1027t, 1267, 1738t, 1748

for agitated behaviors, 2243

for ASD, 1860

for depressive disorders, 1819t, 1820t, 1821t, 2245

for diabetes, 2226t

for OCD, 1756

for panic disorder, 1748

for PTSD, 1754

for vasomotor symptoms, 1036t

Citrulline, 2152

Citrus aurantium, 765t

Cladribine, 469t

Claforan (see Cefotaxime)

Clarinex (see Desloratadine)

Clarithromycin (Biaxin), 120t, 128, 493–494t, 496, 942t, 1325t, 1371, 1607, 1720

adverse effects of, 1332t

for aerobic gram-positive cocci, 1326t

for MAC, 1619

for theophylline metabolism inhibition, 398

Claritin (see Loratadine)

Clavulanate, 461t

Clavulanic acid, 423

Clemastine (Tavist), 433t

Cleocin (see Clindamycin)

Clevidipine (Cleviprex), 335t

for hypertension, 345

Cleviprex (see Clevidipine)

Climara Pro, 1033t

Clindamycin (Cleocin), 1325t, 1607, 1696, 1727

for acne, 829

adverse effects of, 1333t

for aerobic gram-positive cocci, 1326t

for anaerobes, 1328t

for cellulitis, 645

for chorioamnionitis, 996

dosing of, 1337t

for GBS infection, 995

plus gentamicin, 1512–1513t

for skin and soft tissue infections, 1547, 1548, 1549, 1550

Clindamycin-quinine, 1727

Clioquinol, 1624t

Clofarabine (Clolar), 469t, 1996, 1996t

Clofazimine, 1619

C

l

o

fi

b

ri

c

a

c

i

d

,

9

4

2

t

C

l

o

l

a

r

(

s

e

e

C

l

o

fa

r

a

b

i

n

e

)

C

l

o

m

i

p

h

e

n

e

c

i

t

r

a

t

e

(

A

n

t

i

e

s

t

r

o

g

e

n

)

,

9

5

9

,

1

0

1

3

fo

r

p

o

ly

c

y

s

t

ic

o

v

a

r

y

s

yn

dr

o

me

,

1

0

1

2

t

C

l

o

m

i

p

r

a

m

i

n

e

fo

r

A

S

D

,

1

8

5

8

do

s

a

g

e

,

1

7

5

9

fo

r

p

a

nic

dis

o

r

d

e

r

,

1

7

4

8

s

id

e

e

ffe

c

t

s

,

1

7

6

0

C

l

o

n

az

e

p

a

m

,

1

2

7

1

t

,

1

2

7

2

,

1

7

3

7

t

fo

r

A

ka

th

is

ia

,

1

8

0

0

t

fo

r

p

a

nic

dis

o

r

d

e

r

,

1

7

4

8

fo

r

S

A

D

,

1

7

5

2

p. 2

2

9

6

p. 2

2

9

7

C

l

o

n

i

d

i

n

e

(

C

a

t

a

p

r

e

s

)

,

1

5

7

t

,

3

3

6

t

,

1

7

7

6

,

2

2

6

1

t

fo

r

A

D

H

D

,

1

8

6

8

t

,

1

8

7

0

a

lc

o

h

o

l

w

ith

dr

a

w

a

l,

1

8

9

6

fo

r

B

P

,

3

3

9

fo

r

hyp

e

r

t

e

n

s

io

n

,

1

5

9

fo

r

hyp

e

r

t

e

n

s

iv

e

ur

g

e

n

c

y

,

3

3

9

fo

r

op

io

id

w

ith

dr

a

w

a

l

s

yn

dr

o

me

,

1

8

7

8

in

p

a

t

ie

nt

s

w

ith

C

K

D

,

6

1

7

fo

r

s

le

e

p

,

1

8

6

1

fo

r

v

a

s

o

mo

t

o

r

s

ymp

t

o

m

s

,

1

0

3

6

t

C

l

o

p

i

d

o

g

r

e

l

,

2

0

1

,

2

2

8

,

4

8

5

,

1

1

1

6

,

1

3

0

7

t

,

1

3

1

4

fo

r

A

C

S

,

2

3

9

t

,

2

4

4

,

2

4

6–

2

4

7

t

a

nt

ip

la

t

e

le

t

me

dic

a

t

io

n

s

,

4

9

9

a

n

d

a

s

p

ir

in

,

2

3

9

–

2

4

0

t

,

1

3

1

5

fo

r

C

A

D

,

2

2

7

fo

r

dia

b

e

t

e

s

,

1

6

8

drug

int

e

r

a

c

t

io

n

w

ith

s

mo

kin

g

,

1

9

0

6

t

in

fib

r

in

o

lyt

ic

th

e

r

a

p

y

,

2

5

1

fo

r

is

c

h

e

mia

,

2

5

5

lo

a

din

g

do

s

e

,

2

5

5

–

2

5

6

fo

r

M

I

,

2

1

3

fo

r

P

A

D

,

1

6

8

fo

r

ulc

e

r

h

e

a

lin

g

,

4

9

9

C

l

o

r

az

e

p

a

t

e

,

1

7

3

7

t

,

1

7

4

3

C

l

o

t

ri

m

az

o

l

e

,

1

5

2

5

t

,

1

6

2

4

t

C

l

o

x

a

c

i

l

l

i

n

,

1

3

2

5

t

C

l

o

z

a

p

i

n

e

(

C

l

o

z

a

ri

l

)

,

1

2

6

7

,

1

7

9

7

t

,

1

7

9

9

t

,

1

8

0

7

,

1

8

1

1

fo

r

a

c

ut

e

ma

nia

,

1

8

4

4–

1

8

4

5

fo

r

a

g

it

a

t

e

d

b

e

h

a

v

io

r

s

,

2

2

4

4

fo

r

a

nt

ic

h

o

lin

e

r

g

ic

,

1

8

0

1

drug

int

e

r

a

c

t

io

n

w

ith

s

mo

kin

g

,

1

9

0

6

t

fo

r

dy

s

lip

id

e

mia

,

1

8

0

4

fo

r

F

GA

s

,

1

8

0

3

fo

r

o

r

th

o

s

t

a

t

ic

hyp

o

t

e

n

s

io

n

,

1

8

0

1

fo

r

P

a

r

kin

s

o

nis

m

,

1

7

9

8

fo

r

s

c

h

iz

op

hr

e

nia

,

1

7

8

5

,

1

7

8

8

,

1

7

9

1

t

,

1

7

9

2

fo

r

t

a

c

hy

c

a

r

dia

,

1

8

0

1

for Tardive dyskinesia, 1801

Clozaril (see Clozapine)

Coal tar, 1626

for psoriasis, 835t, 837

Cobicistat, 914t

Cobimetinib, 470t

Cocaine, 1177t

CNS stimulants, 1882

and lactation, 1003t

for schizophrenia, 1783, 1783t

teratogenic effects, 973t

Codeine, 59, 677 (see also Opioids)

Coenzyme Q, 304–305

Coenzyme Q10 (CoQ10

), 121